INFINITY PHARMACEUTICALS INC's ticker is and the CUSIP is 45665G953. A total of 3 filers reported holding INFINITY PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $1,165 | -61.2% | 2,100 | 0.0% | 0.00% | – |
Q3 2022 | $3,000 | +200.0% | 2,100 | +50.0% | 0.00% | – |
Q2 2022 | $1,000 | -50.0% | 1,400 | -6.7% | 0.00% | – |
Q1 2022 | $2,000 | -88.2% | 1,500 | -80.5% | 0.00% | – |
Q4 2021 | $17,000 | -94.1% | 7,700 | -90.9% | 0.00% | – |
Q3 2021 | $288,000 | +69.4% | 84,200 | +48.2% | 0.00% | – |
Q2 2021 | $170,000 | -1.2% | 56,800 | +6.4% | 0.00% | – |
Q1 2021 | $172,000 | +975.0% | 53,400 | +602.6% | 0.00% | – |
Q4 2020 | $16,000 | +166.7% | 7,600 | +117.1% | 0.00% | – |
Q2 2019 | $6,000 | -14.3% | 3,500 | 0.0% | 0.00% | – |
Q1 2019 | $7,000 | -22.2% | 3,500 | -54.5% | 0.00% | – |
Q4 2018 | $9,000 | -77.5% | 7,700 | -48.3% | 0.00% | – |
Q3 2018 | $40,000 | +11.1% | 14,900 | -21.6% | 0.00% | – |
Q2 2018 | $36,000 | +24.1% | 19,000 | +37.7% | 0.00% | – |
Q1 2018 | $29,000 | -50.8% | 13,800 | -52.4% | 0.00% | – |
Q4 2017 | $59,000 | -7.8% | 29,000 | -39.8% | 0.00% | -100.0% |
Q3 2017 | $64,000 | +2033.3% | 48,200 | +2735.3% | 0.00% | – |
Q2 2017 | $3,000 | -98.8% | 1,700 | -99.1% | 0.00% | -100.0% |
Q4 2016 | $247,000 | +40.3% | 182,800 | +62.5% | 0.00% | 0.0% |
Q3 2016 | $176,000 | -35.5% | 112,500 | +223.3% | 0.00% | -33.3% |
Q4 2015 | $273,000 | -30.4% | 34,800 | -25.0% | 0.00% | -40.0% |
Q3 2015 | $392,000 | -32.5% | 46,400 | -12.6% | 0.01% | -37.5% |
Q2 2015 | $581,000 | -24.5% | 53,100 | -3.6% | 0.01% | -33.3% |
Q1 2015 | $770,000 | -54.2% | 55,100 | -44.7% | 0.01% | -52.0% |
Q4 2014 | $1,682,000 | -1.1% | 99,600 | -21.4% | 0.02% | -3.8% |
Q3 2014 | $1,700,000 | +35.2% | 126,700 | +28.4% | 0.03% | +36.8% |
Q2 2014 | $1,257,000 | -26.8% | 98,700 | -31.6% | 0.02% | -34.5% |
Q1 2014 | $1,717,000 | -55.8% | 144,400 | -48.7% | 0.03% | -50.8% |
Q4 2013 | $3,888,000 | +199.1% | 281,500 | +277.9% | 0.06% | +136.0% |
Q3 2013 | $1,300,000 | +11.4% | 74,500 | +3.8% | 0.02% | -13.8% |
Q2 2013 | $1,167,000 | – | 71,800 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GROUP ONE TRADING, L.P. | 74,500 | $1,300,000 | 0.02% |
Citadel Advisors | 23,600 | $412,000 | 0.00% |